Nifty’s Pharma index saw a decline after US President Trump announced a 100 percent tariff on branded drugs from October 1. Analysts noted India’s limited exposure to patented drugs in the US market. Most Indian firms focus on generic medicines, which are not affected by the new tariff. Major Indian players also operate manufacturing facilities within the United States.
Top 10 fastest wealth creators: Which stocks made investors richest the fastest in 5 years? Check here
A select set of stocks delivered extraordinary returns between 2020 and 2025, far outperforming the broader market, Motilal Oswal said in its December 2025 Wealth
December 21, 2025